SAIZEN

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, New Zealand, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug SAIZEN contains one active pharmaceutical ingredient (API):

1 Somatropin human recombinant UNII NQX9KB6PCL - SOMATROPIN

Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat. Read about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10442N, 10458K, 10462P, 10483R, 10495J, 10497L, 3388H, 5822K, 5824M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525414030044703, 525414030044803, 525414030044903, 525420501158310, 525420502154319
Country: CA	Health Products and Food Branch	Identifier(s): 02237971, 02350122, 02350130, 02350149
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H7731013, H7741013
Country: EE	Ravimiamet	Identifier(s): 1043705, 1064269, 1415528, 1415539, 1415540, 1415551, 1415562, 1415573
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 73842, 73843
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 072089, 072111, 072122, 072133
Country: FR	Base de données publique des médicaments	Identifier(s): 65196244, 66623496
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 186682, 186690, 186696, 46536
Country: HK	Department of Health Drug Office	Identifier(s): 48913, 61542, 61543, 61544
Country: IE	Health Products Regulatory Authority	Identifier(s): 88202, 88259, 88311
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15527, 15528
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66036001, W66036002, W66037001, W66037002, W66037003, W66037004
Country: SG	Health Sciences Authority	Identifier(s): 07437P, 14425P, 14432P, 14433P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 14663011H, 14663012H, 14663013H, 4043021H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699777794018, 8699808794048, 8699808794055, 8699808794062, 8699808794079, 8699808794086, 8699808794093
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/21.10/0481, Y/21.10/244